Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination
Author:
Affiliation:
1. Department of General Internal Medicine; Kyushu University Hospital; Fukuoka Japan
Funder
JSPS KAKENHI
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15976/fullpdf
Reference35 articles.
1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015;Akinyemiju;JAMA Oncol,2017
2. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis;Ji;J Hepatol,2019
3. HCV cure rates are reduced in patients with active but not inactive hepatocellular carcinoma- a practice implication;Ogawa;Clin Infect Dis,2019
4. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents;Kanwal;Gastroenterology,2017
5. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression;Waziry;J Hepatol,2017
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact;Hepatobiliary Surgery and Nutrition;2024-08
2. Effect of Liver Fibrosis on Oral and Gut Microbiota in the Japanese General Population Determined by Evaluating the FibroScan–Aspartate Aminotransferase Score;International Journal of Molecular Sciences;2023-08-30
3. Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response;Journal of the Chinese Medical Association;2023-07-19
4. Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study;Cancer Medicine;2022-10-13
5. Risk stratification and early detection biomarkers for precision HCC screening;Hepatology;2022-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3